Received Jun 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Penmenvy components were not mixed and received only the men B component; Penmenvy components were not mixed and received only the men B component; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe for prophylaxis. On 28-MAY-2026, the patient received Penmenvy. On 28-MAY-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Penmenvy components were not mixed and received only the men B component) and inappropriate dose of vaccine administered (Verbatim: Penmenvy components were not mixed and received only the men B component).The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:01-JUN-2026 The reporter asked if the entire vaccine dose need readministered. The batch number was not provided upon follow up with the reporter.